Global Health News Last Week



  • A paper published in Science by a research group at the University of Maryland demonstrates that a fungus, Metarhizium anisopliae, can be used to combat the malarial parasite inside the mosquito. Another promising study suggests that a compound produced by a seaweed in Fiji could be used to combat malaria.
  • A new study has shown that that Internet kiosks providing information on prenatal and postnatal care have helped reduce infant, child, and maternal mortality rates in rural India.
  • A study published by the Harvard School of Public Health last year found that the poorest third of the world’s population account for only 4% of surgeries worldwide, and that over two million people in low-income countries have no access to life-saving surgery.
  • The first phase trials of the HIV vaccine developed in India were completed with no side effects reported. Meanwhile, a three-year research trial on a vaginal anti-HIV gel has been launched in Rwanda.
  • The Trachoma Atlas, an open-access resource on the geographical distribution of trachoma, was launched by a team of collaborators from the London School of Hygiene & Tropical Medicine, the International Trachoma Initiative at The Task Force for Global Health, and the Carter Center. It is funded by a generous donation from (you guessed it!) the Bill & Melinda Gates Foundation.
  • The European Solutions Enterprise for Neglected Diseases (euSEND), a new initiative, based in the Netherlands, was launched to aid in the fight against neglected tropical diseases. The organization’s goal is to “take the role of matchmaker” to facilitate partnerships in research for NTD treatments and vaccines.


  • Swaziland has a large-scale circumcision drive in an attempt to lower HIV rates.
  • Cash-transfer programs as a means of assisting the poor are beginning to gain attention and popularity from development and economic professionals. Mexico’s and Brazil’s have captured particular attention and are credited with poverty reduction and GDP growth.
  • The first methadone maintenance program in sub-Saharan Africa recently opened in a hospital in Dar es Salaam, Tanzania. Heroin use is a growing problem in port cities, where the drug passes through en route from Afghanistan to Europe.


Punished for the crimes of politicians: Zambians suffer as donors pull aid over accusations of corruption

The Global Fund to Fight AIDS, Tuberculosis, and Malaria has not distributed its grants to Zambia’s Ministry of Health since last August.1  The decision was made after Sweden and the Netherlands suspended aid when evidence of fraud was discovered in the Ministry of Health: senior officials have been charged with stealing US$5 million.2 The Fund demanded that the Ministry of Health return US$8 million in unspent funds and that the government take action against corruption within their ranks.  US$17 million in aid have been distributed through other channels, and the United Nations Development Programme will take over the management of the Ministry’s grants.1 

Though the Fund expects full grant activities to resume within the next two months,1 Zambians in rural areas are feeling the impact of the suspension.  Outreach programs for persons living with HIV, such as mobile counseling and testing and ART services, have stopped.3  Rural residents living with HIV have been traveling to urban health centers to get drugs, when health workers previously brought the drugs to them.  Obert Mubyana, district HIV and TB programmes officer for the Mpulungu district, said,

“The past three or four months, the situation has been very bad. We are not able to travel … [and] have a lot of patients that we need to monitor.  …[we have] to carry out mobile VCT, mobile ART, we need fuel, we need allowances, so we have had to suspend a lot of programmes.”   

Donor funds make up over half of Zambia’s health budget toward programs for malaria, TB, and HIV and training medical staff, so this suspension has raised concerns of a health crisis in the country.4  Many Zambians feel they are being punished.3  While it is certainly a donor’s right to withdraw help if it is being abused, it still begs the question: are citizens of countries that receive international aid unfairly punished for the crimes of their politicians when that aid is withdrawn?  Is it short-sighted to target direct services with aid money, rather than trying to use it to build a country’s capacity to administer such services on its own?  Can such a capacity even be built with donor funds?  And how much sense does it make to suspend aid over allegations of corruption, when a certain baseline level of graft and embezzlement is already expected?

Though there are no easy answers to these questions, Zambia still needs them.  The national average of HIV prevalence is officially estimated at 14 percent, but unofficial statistics from local health facilities suggest that the actual number may be around 50 percent.3  The Global Fund’s grants provide HIV treatment to over 200,000 Zambians, so a disruption of such aid would be devastating.